◀ Back to CDK2

CDK2 — PARP9

Text-mined interactions from Literome

Korhonen et al., Neurosci Lett 2005 (Nerve Degeneration) : MK-801 ( NMDA receptor antagonist ) as well as benzamide ( PARP inhibitor ), MDL 28170 ( calpain inhibitor ) and roscovitine ( cyclin dependent kinase inhibitor ) inhibited the glutamate response to the YY1 complexes
Brun et al., Bioorg Med Chem 2005 : They increase inhibitory tyrosine 15 phosphorylation of CDK and induce the cleavage of PARP , a hallmark of apoptosis